Fundz

Fundz Deep Dive

Everything you need to win Terry Kohler — in one platform.

Who to reach, what to say, and why now on Terry Kohler — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Terry Kohler — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Optinose Appoints Terry Kohler As Chief Financial Officer

PRIVATEOct 07, 2024over 1 year ago

Position

Chief Financial Officer

Company

Optinose

Terry Kohler
YardleyHealthcare

Description

Optinose has appointed Terry Kohler as Chief Financial Officer. Terry brings over 20 years of experience as a biotech finance leader, previously serving as the Chief Financial Officer for Verrica Pharmaceuticals and in various leadership roles at Endo International PLC.

Company Information

Company

Optinose

Location

1020 STONY HILL ROAD

Yardley, Pennsylvania, United States

About

Optinose is a biopharmaceutical company specializing in the development of unique therapeutics for patients with ear, nose, and throat conditions. The company's leading product, XHANCE, is designed for the treatment of chronic rhinosinusitis. Optinose is dedicated to addressing unmet medical needs through its innovative approaches. The focus is on expanding treatment options for patients suffering from CRS.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Optinose's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.